PF-06664178

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06664178, covering 2018-02-19 to 2018-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-06664178 In Patients With Advanced Solid Tumors [Phase 1]